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Nanotechnology is a new discipline with huge applications including medicine and pharmacology industries. Although several
methods and reducing agents have been employed to synthesize silver nanoparticles, reactive chemicals promote toxicity and
nondesired effects on the human and biological systems. The objective of this work was to synthesize silver nanoparticles
from Glycyrrhiza glabra and Amphipterygium adstringens extracts and determine their bactericidal and antimycotic activities
against Enterococcus faecalis and Candida albicans growth, respectively. 1 and 10mM silver nitrate were mixed with an extract
of Glycyrrhiza glabra and Amphipterygium adstringens. Green silver nanoparticles (AgNPs) were characterized by TEM, Vis-
NIR, FTIR, fluorescence, DLS, TGA, and X-ray diffraction (XRD) analysis. Bactericidal and antimycotic activities of AgNPs were
determined by Kirby and Bauer method and cell viability MTT assays. AgNPs showed a spherical shape and average size of 9 nm
if prepared with Glycyrrhiza glabra extract and 3 nm if prepared with Amphipterygium adstringens extract. AgNPs inhibited the
bacterial and fungal growth as was expected, without a significant cytotoxic effect on human epithelial cells. Altogether, these
results strongly suggest that AgNPs could be an interesting option to control oral biofilms.
1. Introduction
Nanotechnology is a relative new discipline with huge appli-
cations in many areas including medicine and pharmacology
industries [1, 2]. The increasing development of multidrug-
resistant strains among pathogen microbes has become
one of the most important problems in medicine world-
wide [3]. Great advances in nanotechnology have provided
a solid foundation for using nanoparticles (NPs) in the
fight against pathogenmicroorganisms, includingmultidrug-
resistant bacteria [2, 4, 5]. Previously the biocidal proper-
ties of nanoclusters of several metals have been described,
mainly, silver, gold, zinc, titanium, and bismuth [6–10]. Aside
from their potential metal nanoparticles present cytotoxicity
on human cells, this may occur in all reactive chemicals
employed in their synthesis and limiting their use in clinical
practice [11–14].
The traditional synthesis of silver nanoparticles (AgNPs)
uses chemical reducing agents to modify Ag ions to AgNPs
[15]. The most common used chemical reducing agents are
ascorbic acid [16], hydrazine [17], and sodium borohydride
[18]. The use of these composites involves undesired side
effects and the biocompatibility of resulting AgNPs is low for
being employed in biological systems. Recently newmethods
based on green synthesis that use environmental compounds
as reducing agents are emerging [19–22]. Plants, bacteria,
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fungus, and algae have been used for green synthesis of metal
nanoparticles with very good results and water acts as a
solvent in the process of green synthesis [23].
AgNPs are synthesized using a green synthesis method.
AgNPs are being investigated for application in biomedicine
and to be used as bactericide agent or for cancer treat-
ment [24]. Several plants have been used to prepare silver
nanoparticles; for example, Alfalfa and Geranium (one of the
first plants used for these porpoise) produce nanoparticles
with sizes of 2–20 nm and 14–46 nm, respectively [25, 26].
Recently, Phanjom et al. (2012) used Elaeagnus latifolia leaf
extract to synthesize AgNPswith diameters of 30–50 nm [27];
also AgNPs with potential cytotoxic effects against breast
cancer cells were prepared using Ganoderma neojaponicum
Imazeki [28].
The objective of this work was to synthesize silver
nanoparticles from Glycyrrhiza glabra and Amphipterygium
adstringens and determine their bactericidal and antimycotic
activities against Enterococcus faecalis and Candida albicans
growth, respectively; to our knowledge this is the first report
for the green synthesis of silver nanoparticles using these
plants. The obtained results show AgNPs of spherical shape
and average size lower than 10 nm. As was expected, AgNPs
inhibited the bacterial and fungal growth corroborating
their biological properties. Altogether, these results strongly
suggest that gAgNPs could be an interesting option to control
oral biofilms.
2. Material and Methods
2.1. Achievement of Glycyrrhiza glabra and Amphipterygium
adstringens Ethanolic Extracts. Bark of Amphipterygium
adstringens (Cuachalalate) and root of Glycyrrhiza glabra
were employed to get ethanolic extracts following themethod
previously described by Viveros-Valdez et al., 2008. 250 g
of A. adstringens was macerated and put into water in a
relation of 50 : 50, H
2
O :C
2
H
6
O. In the case of G. glabra
extract,methanolwas employed to dilute themacerated. Both
extracts were maintained in continuous agitation for 24 h at
room temperature, thus getting 3 extractions, and solvent was
eliminated by reduced pressure [29]. A phytochemical analy-
sis of extracts was done to partially identify active ingredients
through chemical assays like Shinoda, Liebermann Burchard,
coumarins, and so forth [30]. The semicharacterized extracts
were stocked at 4∘C until being used to synthesize silver
nanoparticles.
2.2. Biosynthesis of Silver Nanoparticles, gAgNPs. All reagents
were purchased from Sigma-Aldrich Co. and were used
without further purification. Deionized water was used to
prepare all the aqueous solutions.
2.3. Preparation of the Extract Solution. For the preparation
of the extract solutions, a given amount of the dried extract
was diluted with dimethyl sulfoxide DMSO to obtain a final
concentration of 0.4% (w/v).Once obtained, this solutionwas
stored at 4∘C and protected from the sunlight until being
used.
2.4. Synthesis of Silver Nanoparticles. Under ambient condi-
tions andmagnetic stirring, 100 𝜇L of the extract solutionwas
added to 25mL of either 1mM or 10mM AgNO
3
aqueous
solution (we obtained 4 different samples, two for the
Glycyrrhiza glabra extract and two for the Amphipterygium
adstringens extract; see labels for each sample in Table 2).
Immediately after that, the pH value of the reaction mixture
was adjusted to 11 using a 3.0M NaOH solution and then it
was stirred for another 15 minutes.
After that time, the pH value of the reaction mixture was
again modified to 1.0 using HNO
3
(63%); this modification
of pH produces a reversible flocculation of the nanoparticles,
allowing us to easily separate them from the subproducts of
the reaction by centrifugation at 6000 rpm. The supernatant
was discarded and the pellet was redispersed using deionized
water and, if necessary, the pH was adjusted to 7.0.
To obtain dried powders of the nanoparticles, after the
centrifugation, the separated pellet was dried overnight in a
conventional oven at 60∘C.
2.5. Characterization of the Silver Nanoparticles. The mor-
phology and size of the silver nanoparticles were analyzed
using transmission electron microscopy (TEM) with a JEOL
JEM1230 microscope operating at an acceleration voltage
of 100 kV. TEM images of the prepared nanoparticles were
used for the size distribution measurements; the size of
300 particles was measured to obtain the average size. Vis-
NIR absorption spectra were obtained using a CHEMUSB4-
VIS-NIR (Ocean Optics) spectrophotometer. Hydrodynamic
diameter and zeta potential were measured using dynamic
light scattering (DLS) with a Zetasizer Nano ZS (Malvern
Instruments) operating with a He-Ne laser at a wavelength
of 633 nm and a detection angle of 90∘ at 25∘C. Fluorescence
emission (FLUO) was observed using a USB4000 spec-
trophotometer (Ocean Optics); samples were excited with
a solid state continuous laser (532 nm, 100mW). All of the
above characterization techniques were performed using the
aqueous dispersion of the nanoparticles.
Using the dried powders, X-ray diffraction (XRD) pat-
terns were obtained on a GBC-Difftech MMA model, with
a Cu K𝛼 irradiation at 𝜆 = 1.54 A˚; thermogravimetric analysis
(TGA) was performed in a DSC500 calorimeter (Waters),
using a constant heating rate of 2∘C/min from room temper-
ature to 1000∘C; infrared spectra (IR) were obtained with a
FTIR spectrophotometer (IRAffinity, Shimadzu) from 400 to
4000 cm−1.
2.6. Antimicrobial Activity of AgNPs by Kirby and Bauer
Method and Cell Viability MTT Assay. The bactericidal
and antifungal activities of AgNPs on Enterococcus faecalis
and Candida albicans growth (ATCC numbers: 11420 and
90029) were determined using Kirby and Bauer disk dif-
fusion method [31] and MTT (3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide) assay (Biotium, Hayward,
CA) [32] following the instructions of the manufacturer. E.
faecalis and C. albicans were grown in trypticase soy broth
(TSB, BD DIFCO, Sparks, MD, USA) at 37∘C, overnight in
aerobic conditions. 100 𝜇L of microbial culture was spread
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on TSB agar plate using a sterile cotton swab. AgNPs were
embedded into the agar plate to interfere with bacterial
growth. The Petri plate was incubated at 37∘C overnight and
the inhibition of bacterial growthwas directly proportional to
diameter of halo measured with a Vernier. Experiments were
repeated three times to assess the veracity of results.
The cell viability was evaluated by the amount of viable
cells stained by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
tetrazolium bromide (Biotium, Hayward, CA) which was
released with dimethylsulfoxide (DMSO, Sigma-Aldrich Inc.,
St. Louis, MO, USA). E. faecalis and C. albicans were grown
in trypticase soy broth (TSB, BD DIFCO, Sparks, MD, USA)
at 37∘C, overnight in aerobic conditions. The microbial cells
were counted using a Neubauer chamber and 1 × 104 cells
were inoculated in 100𝜇L of trypticase soy broth medium in
a 96-well polystyrene plate. Three wells with only trypticase
soy broth medium were used as controls for microbial
growth and AgNPs at final concentration of 0.1 and 1mM
were added. 1.2mM of chlorhexidine (Ultradent Products,
South Jordan, UT) and 0.2mM of colloidal silver (Microdyn,
Tavistock, B) were employed as positive inhibitors of bacterial
growth, while 0.002mM of amphotericin B (Pisa, Mexico)
and 0.2mMof colloidal silver were used as positive inhibitors
of fungal growth. AgNPs at final concentration of 1 and
10mM were used to assess their antimicrobial activity. The
96-well plate was incubated at 37∘C overnight. Next, 10 𝜇L
of MTT was added to each well to get a final concentration
of 0.1mg/mL; the plate was protected against light and
incubated at 37∘C for 2 h. Next, 200𝜇L of dimethyl sulfoxide
was added to dissolve the reduced MTT species. The amount
of cells alive was determined using a microplate absorbance
reader (Biorad, Philadelphia, PA) at 570 nm.The experiments
were repeated three times and the measured optical density
was analyzed by descriptive statistics.
2.7. Cytotoxicity of Silver Nanoparticles Biosynthesized with
G. glabra and A. adstringens Ethanolic Extracts. In order to
get insight into possible nondesired effects of AgNPs, in this
research we used human epithelial cells (HeLa) to analyze the
cytotoxic effects of AgNPs. A confluent monolayer of 1 × 105
HeLa cells (ATTCC Nro. CCL-2) was grown in Minimal
Essential Medium (MEM, Invitrogen, Carlsbad, CA) supple-
mented with 10% of Fetal Bovine Serum (FBS, Invitrogen,
Carlsbad, CA) at 37∘C with 5% of CO
2
in 96-well microtiter
plates (Thermo Fisher Scientific Inc.). It was exposed to
1–0.015mM of AgNPs for 24 h, and the possible cytotoxic
effect was detected by MTT (3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide) assay (Biotium, Hayward,
CA) [32]. As negative control, cells without nanoparticles
were employed. 10 𝜇L of MTT was added to each well; the
plate was protected against light and incubated at 37∘C for
2 h. Next, themediumwas removed carefully and then 100 𝜇L
of dimethyl sulfoxide was added to dissolve the reduced
MTT species.The amount of cells alive was determined using
a microplate absorbance reader (Biorad, Philadelphia, PA)
at 570 nm. The experiments were repeated three times and
the measured optical density was analyzed by descriptive
statistics.
Table 1: Phytochemical analysis of ethanolic extracts ofGlycyrrhiza
glabra root and Amphipterygium adstringens bark.
Phytochemical component Glycyrrhizaglabra
Amphipterygium
adstringens
Alkaloids ND ND
Flavonoids + ND
Carbohydrates + +
Saponins ND ND
Tannins + +
Double bonds + +
Carbonyl groups + +
Sterols and triterpenes + +
Coumarins + +
Sesquiterpene lactones ND ND
Quinones ND ND
+: identified; ND: not detected.
3. Results
3.1. Glycyrrhiza glabra and Amphipterygium adstringens
Ethanolic Extracts. The phytochemical screening of extracts
showed the presence of tannins, sterols, triterpenes, and
coumarins (Table 1). Flavonoids were detected in G. glabra
extract but they were undetectable in A. adstringens extract.
This result is very interesting due to early reports indicating
a clear correlation between strong antioxidant activity and
phenolic and flavonoids contents [33]. In theory, the major
content in flavonoids in G. glabra extract could reduce silver
nitrate more successfully than A. adstringens extracts.
3.2. Synthesis of Nanoparticles. The addition of the extract
to the AgNO
3
solution produces a change in color from
colorless to pale yellow; when we added the NaOH solution
the reaction mixture immediately changes from pale yellow
to light brown (for the 1mM solutions) and to black (for
the 10mM solutions); this change in color is an indicator of
the immediate formation of the nanoparticles; the addition
of NaOH in a green synthesis has already been reported by
Singh et al. (2009); they also used NaOH as an accelerator of
the reaction [34].
During the next 15 minutes of stirring an Ostwald ripen-
ing process occurs and allows the population of nanoparticles
to bemore homogeneous in size. No important changes in the
properties of the silver nanoparticles were observed when the
concentration of the silver nitrate solution changed.
3.3. Characterization of Silver Nanoparticles. Figure 1 pre-
sents TEM images and histograms of the four samples
obtained in this work; all of them have a narrow particle size
distribution and spherical morphology. As we can see, sam-
ples prepared using the Gg extract are bigger than samples
prepared using the Aa extract (see Table 2). Table 2 also
presents the results of theDLS analysis; it can be observed that
the hydrodynamic size of all samples is bigger probably due
to the presence of biomolecules in their surface (the presence
of these biomolecules was further confirmed by FTIR and
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Figure 1: Continued.
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Figure 1: TEM images and histograms for size distribution of silver nanoparticles biosynthesized from Glycyrrhiza glabra and
Amphipterygium adstringens. (a) Sample AgG1, (b) sample AgG10, (c) sample AgA1, and (d) sample AgA10.
Table 2: Size and zeta potential of the four samples prepared in this
work.
Sample∗ Size TEMM ± SD (nm)
Hydrodynamic
diameter
M ± SD (nm)
Zeta potential (mV)
AgG1 9.7 ± 3.8 25.39 ± 3.89 −42.5 ± 11.2
AgG10 9.5 ± 2.9 7.892 ± 0.82 −31.9 ± 9.12
AgA1 3.1 ± 1.2 133.7 ± 24.16 −50.9 ± 10.3
AgA10 3.9 ± 1.1 42.69 ± 7.24 −42.3 ± 7.52
∗G means samples prepared with Glycyrrhiza glabra and A means samples
preparedwithAmphipterygium adstringens. 1 and 10 are for samples prepared
with AgNO3 at 1 and 10mM, respectively.
TGA analyses); potential zeta values range from −31.9mV to
−50.9mV.
TheVis-NIR spectra are presented in Figure 2; differences
in size are not reflected in the position of the surface
plasmon resonance (SPR); all samples have the characteristic
SPR of silver nanoparticles at 420 nm; these spectra are
narrow reflecting the narrow particle size distribution of the
samples; it has been reported that the nature of the extract
modifies the position of the plasmon and similar results were
reported for nanoparticles synthesized with Chrysopogon
zizanioides, Prosopis juliflora,Moringa oleifera, and Indigofera
aspalathoides [35].
Figure 3 shows the diffraction patterns of the samples
obtained at 10mMAgNO
3
solution for both extracts; samples
can be indexed as pure metallic silver (JCPDS 04-0783)
without the presence of any other phases; broader peaks can
be seen for sample AgA10 due to the lower particle size and
probably due to a lower crystallinity.
FTIR spectra are shown in Figure 4; we found peaks
for both samples (AgA and AgG) at 1015 cm−1 (C-N stretch,
aliphatic amines), 1385 cm−1 [C-C stretch (in-ring), aro-
matics], 1595 cm−1 (N-H bend, primary amines), 1737 cm−1
(C=O stretch; esters, saturated aliphatic), 1990 cm−1 (-C≡C-
stretch, alkynes), 2849 cm−1 (H-C=O: C-H stretch, aldehy-
des), 2920 cm−1 (C-H stretch, alkanes), 3302 cm−1 only for
G extract (O-H stretch, H-bonded; alcohols, phenols), and
3758 cm−1 (O-H stretch, primary alcohol) only for G extract;
similar results were reported by [36, 37].
As a remarkable feature of the nanoparticles prepared
with the extracts of both A. adstringens and G. glabra we
found that when irradiated with a 532 nm wavelength laser,
they present an emission band with a maximum at 580 nm
(Figure 5).This emission band is most probably coming from
the extractmolecules in the surface of the silver nanoparticles
because it has been reported that only ultrasmall metal
nanoclusters could present this property intrinsically [38].
3.4. Antimicrobial Activity of AgNPs by Kirby and Bauer
Method and Cell Viability MTT Assay. In order to determine
if the biosynthesized silver nanoparticles have bactericidal
and antimycotic activities Kirby and Bauer disk diffusion
assays were performed. The results showed that inhibition
of Enterococcus faecalis and Candida albicans growth with
AgNPs developed with both extracts (samples AgA10 and
AgG10) as can be seen in Figure 6 with average inhi-
bition zone of 10mm. Samples AgA1 and AgG1 did not
show a relevant inhibition of microbial growth; this may
be due to incomplete reduction of silver nitrate or due
to the extract molecules surrounding the surface of the
nanoparticles causing agglomeration and passivation (see
Figure S1 in Supplementary Material available online at
http://dx.doi.org/10.1155/2016/9204573). These results were
expected based on the size and morphology of AgNPs, since
spherical morphology, concentration, and low size are tightly
related to their biological action. With the intention of cor-
roborating the antimicrobial activity of AgNPs, cell viability
MTT assays were carried out. Again silver nanoparticles
6 Journal of Nanomaterials
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Figure 2: Vis-NIR spectra of the silver nanoparticles. (a) Samples prepared with Gg extract and (b) samples prepared with Aa extract. The
characteristic surface plasmon resonance is located at 420 nm for each sample.
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Figure 3: X-ray diffraction patterns of the samples obtained at the
higher concentrations of AgNO
3
. Samples were identified as pure
silver.
exhibited bactericidal and fungicidal activities, decreasing the
microbial growth until 90% (Figures 6 and 7). To compare
the bactericidal activity of silver nanoparticles 1.2mM of
chlorhexidine and 0.2mM of colloidal silver were employed,
while for antimycotic activity 2.5 𝜇g/mL of B amphotericin
and 0.2mM of colloidal silver were used. 1mM of silver
nanoparticles inhibited 90% of bacterial growth, while 76%
and 41% were blocked by chlorhexidine and colloidal silver,
respectively. 1mM of silver nanoparticles inhibited 78% of
fungal growth while amphotericin B and colloidal silver
interfere with 81% and 41% of fungal growth. In summary,
silver nanoparticles synthesized by green method compete in
efficacy with commercial products.
3.5. Cytotoxicity of AgNPs on Human Epithelial Cells. The
cytotoxic effect of biosynthesized silver nanoparticles was
evaluated in human epithelial cells by cell viability MTT
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Figure 4: FTIR analysis of the functional groups adsorbed on the
surface of the silver nanoparticles.
assay. The obtained results indicate that silver nanoparticles
developed with A. adstringens extract were more toxic to
human cells instead of nanoparticles synthetized with G.
glabra extract (Figure 8). The cytotoxic potential of silver
nanoparticles on human cells [11, 15] is well described; how-
ever, silver nanoparticles synthesized with G. glabra extract
showed less side effects and they exhibited a good antimi-
crobial activity. In summary, side effects and antimicrobial
activitymust be evaluated before a possible clinical use of this
kind of nanoparticles.
4. Discussion
Nanotechnology is a relative new discipline with high poten-
tial in pharmaceutical industry and biomedical sciences
Journal of Nanomaterials 7
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Figure 5: Emission spectra of AgNPs prepared in this work. A maximum at 580 nm can be observed. The excitation was done at 532 nm,
100mW power.
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Figure 6: Antimicrobial activity of silver nanoparticles biosynthesized against Enterococcus faecalis and Candida albicans growth. The
antimycotic activity of AgNPs was tested against C. albicans and bactericidal activity against E. faecalis employing Kirby and Bauer diffusion
disk method. The average diameter halo of microbial inhibition is proportional to the activity of AgNPs. G means Glycyrrhiza glabra and A
Amphipterygium adstringens, respectively, diluted 10−2 or 10−3.
[39–43]. Nanotechnology applied to medicine tackles fun-
damental problems like cancer treatment, multiresistance
among pathogen microorganisms, vaccines, biotechnol-
ogy devices, molecular machine systems, and so forth.
Nanoparticle-based therapywould be the evolutionatedmed-
ical treatment with “smart” therapeutics that is simultane-
ouslymore potent with less toxic drugs [5].Metallic nanopar-
ticles are frequently developed by chemical and physical
methods [44]. However, in order to look for ecofriendly and
green synthesis of metallic NPs diverse biological entities
like microorganisms, plant extracts, and enzymes are being
employed [44].
In this work we describe a green method to syn-
thesize silver nanoparticles employing Glycyrrhiza glabra
and Amphipterygium adstringens ethanolic extracts; to our
knowledge this is the first report for the green synthesis
of silver nanoparticles using extracts of these plants. The
name and structure of the constituents in the ethanolic
extracts of Glycyrrhiza glabra and Amphipterygium adstrin-
gens have been reported elsewhere; for Glycyrrhiza glabra,
Alwan et al. (2015) [45] reported glycyrrhizic acid as the
main biologically active component and triterpene saponins,
flavonoids, isoflavonoids, and chalcones as secondary com-
ponents; molecular structures of these compounds can be
found in the review of Asl and Hosseinzadeh (2008) [46–48].
For Amphipterygium adstringens, Navarrete et al. (2005) [49]
mention triterpenoids and long-chain phenols as the major
components of the methanolic extracts; molecular structures
can be found in Khadem and Marles (2010) [47, 50, 51].
In ourwork, in addition to themolecules already reported
we found the presence of tannins (see Table 1); tannins are
polyphenolic molecules present in most natural extracts.
Although it is possible that all molecules in the extracts
play a role in the nucleation of silver nanoparticles we believe
that tannins play the major role. In our procedure (for
both extracts) the nucleation begins with the addition of
8 Journal of Nanomaterials
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Figure 8: Cytotoxicity of silver nanoparticles determined by cell
viability MTT assays. The possible cytotoxic effect of AgNPs syn-
thesized with different concentrations of Aa or Gg extracts was
evaluated in HeLa cells. As positive control HeLa cells growing in
culture media were used. All experiments were done in triplicate to
assess the veracity of results.
NaOH; this change in the pH hydrolyzes tannins into glucose
and gallic acid; once gallic acid is formed the reduction of
silver ions is achieved by the oxidation reaction of phenol
groups. Following the results of the infrared analysis we
propose that tannins, flavonoids, and carbohydrates take part
in the stabilization process of silver nanoparticles. Silver
nanoparticles obtained were spherical in shape with an
average size under 10 nm; here, flavonoids and tannins are the
molecules responsible for the reduction and stabilization of
the nanoparticles through their -OH groups.These results are
similar to AgNPs obtained through green synthesis employ-
ing Artemisia absinthium aqueous extract and bark extracts
of Ficus benghalensis and Azadirachta indica as reductor
agents [48, 50]. Their efficacy in inhibiting the Enterococcus
faecalis and Candida albicans growth was similar to that
obtained with chemical methods [18], competing against
commercial products even better than colloidal silver. AgNPs
synthesized with G. glabra show more antimicrobial activity
than nanoparticles developed with A. adstringens. Previous
reports indicate a clear correlation between strong antioxi-
dant activity and phenolic and flavonoids contents [33] and
the phytochemical analysis showed the presence of flavonoids
only in G. glabra ethanolic extracts. These flavonoids and the
major quantity of the G. glabra extract in the surface of the
nanoparticles (see Figure S2) compared with those prepared
with the A. adstringens extract could be responsible for the
differences in the antibacterial activity.
It would be interesting to try the synthesis of AgNPs with
purified flavonoids and compare the biocidal activity of the
obtained nanoparticles.
When cytotoxicity of AgNPs was explored on human
epithelial cells, the results showed that the addition of AgNPs
developed with A. adstringens extract was more toxic to
human cells instead of nanoparticles synthetized with G.
glabra extract (Figure 8). Several reports described toxic effect
of silver nanoparticles on human cells, limiting their use in
clinical treatments [15]. However, green synthesis did not
exclude cytotoxicity in silver nanoparticles like Safaepour
report in 2009 using Pelargonium graveolens andAzadirachta
indica as reductor agents [51]. More studies are needed
to understand the complete effects of employing biological
systems to biosynthesize metallic nanoparticles.
5. Conclusions
In summary, silver nanoparticles biosynthesized with Gly-
cyrrhiza glabra root and Amphipterygium adstringens bark
extracts inhibited the bacterial and fungal growth suggesting
that green synthesis could be an interesting option to develop
silver nanoparticles with biocidal properties.
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